GlassScriptPhysician profile
David Bass
NPI 1497045900
$1,348.28
in general payments reported to CMS, 2019-2025
20 companies · $769 in 2025
The $769 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.60 · 2021: $136 · 2022: $13.89 · 2023: $139 · 2024: $277 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $266.25 | 2021-2025 | |
| Amgen INC. | $181.83 | 2024-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $142.13 | 2024-2025 | Verquvo, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $111.06 | 2025 | Uptravi, Opsumit |
| Irhythm Technologies, INC. | $93.36 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $64.75 | 2021-2024 | Amplatzer Amulet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.12 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $53.48 | 2024-2025 | Wegovy |
| Baxter Healthcare | $51.17 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $49.35 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $49.27 | 2024-2025 | |
| Bridgebio Pharma, INC. | $43.33 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $38.41 | 2023 | Inpefa |
| Janssen Pharmaceuticals, INC | $30.88 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $27.32 | 2025 | Watchman |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.88 | 2025 | Lifevest |
| Inspire Medical Systems, INC. | $20.77 | 2025 | Inspire |
| Pfizer INC. | $15.43 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 | |
| Medtronic Vascular, INC. | $13.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.